Asher Gary N, Gartlehner Gerald, Gaynes Bradley N, Amick Halle R, Forneris Catherine, Morgan Laura C, Coker-Schwimmer Emmanuel, Boland Erin, Lux Linda J, Gaylord Susan, Bann Carla, Pierl Christiane Barbara, Lohr Kathleen N
1 Department of Family Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC.
2 RTI International, Research Triangle Park , NC.
J Altern Complement Med. 2017 Dec;23(12):907-919. doi: 10.1089/acm.2016.0261. Epub 2017 Jul 12.
To report the comparative benefits and harms of exercise and complementary and alternative medicine (CAM) treatments with second-generation antidepressants (SGA) for major depressive disorder (MDD).
Systematic review and meta-analysis.
Outpatient clinics.
Adults, aged 18 years and older, with MDD receiving an initial treatment attempt with SGA.
Any CAM or exercise intervention compared with an SGA.
Treatment response, remission, change in depression rating, adverse events, treatment discontinuation, and treatment discontinuation due to adverse events.
We found 22 randomized controlled trials for direct comparisons and 127 trials for network meta-analyses, including trials of acupuncture, omega-3 fatty acids, S-adenosyl methionine, St. John's wort, and exercise. For most treatment comparisons, we found no differences between treatment groups for response and remission. However, the risk of bias of these studies led us to conclude that the strength of evidence for these findings was either low or insufficient. The risk of treatment harms and treatment discontinuation attributed to adverse events was higher for selective serotonin receptor inhibitors than for St. John's wort.
Although we found little difference in the comparative efficacy of most CAM therapies or exercise and SGAs, the overall poor quality of the available evidence base tempers any conclusions that we might draw from those trials. Future trials should incorporate patient-oriented outcomes, treatment expectancy, depressive severity, and harms assessments into their designs; antidepressants should be administered over their full dosage ranges; and larger trials using methods to reduce sampling bias are needed.
报告运动及补充与替代医学(CAM)疗法与第二代抗抑郁药(SGA)治疗重度抑郁症(MDD)的相对益处和危害。
系统评价与荟萃分析。
门诊诊所。
年龄在18岁及以上、患有MDD且初次尝试使用SGA治疗的成年人。
将任何CAM或运动干预与SGA进行比较。
治疗反应、缓解情况、抑郁评分变化、不良事件、治疗中断以及因不良事件导致的治疗中断。
我们发现了22项用于直接比较的随机对照试验和127项用于网状荟萃分析的试验,包括针灸、ω-3脂肪酸、S-腺苷甲硫氨酸、圣约翰草提取物和运动的试验。对于大多数治疗比较,我们发现治疗组在反应和缓解方面没有差异。然而,这些研究的偏倚风险使我们得出结论,这些发现的证据强度较低或不足。与圣约翰草提取物相比,选择性5-羟色胺再摄取抑制剂导致治疗危害和因不良事件导致治疗中断的风险更高。
尽管我们发现大多数CAM疗法或运动与SGA在比较疗效上差异不大,但现有证据基础的整体质量较差,这使得我们从这些试验中得出的任何结论都受到影响。未来的试验应在设计中纳入以患者为导向的结果、治疗预期、抑郁严重程度和危害评估;抗抑郁药应在其全剂量范围内给药;需要采用减少抽样偏倚方法的更大规模试验。